About Arkis BioSciences
Arkis BioSciences is a company based in Knoxville (United States) founded in 2011 was acquired by Integra LifeSciences in July 2019.. Arkis BioSciences has raised $9.38 million across 3 funding rounds from investors including Integra LifeSciences, Innova Memphis and The Lighthouse Fund. Arkis BioSciences operates in a competitive market with competitors including Rapid Medical, CoAxia, Cerus Endovascular, Anaconda Biomed and Oxford Endovascular, among others.
- Headquarter Knoxville, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.38 M (USD)
in 3 rounds
-
Latest Funding Round
$4.48 M (USD), Series A
Jan 11, 2018
-
Investors
Integra LifeSciences
& 3 more
-
Employee Count
Employee Count
-
Acquired by
Integra LifeSciences
(Jul 29, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Arkis BioSciences
Arkis BioSciences has successfully raised a total of $9.38M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $4.48 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $4.5M
-
First Round
First Round
(01 Mar 2013)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2018 | Amount | Series A - Arkis BioSciences | Valuation |
investors |
|
| Jun, 2016 | Amount | Series A - Arkis BioSciences | Valuation | Innova Memphis | |
| Mar, 2013 | Amount | Seed - Arkis BioSciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Arkis BioSciences
Arkis BioSciences has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Integra LifeSciences, Innova Memphis and The Lighthouse Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in high-growth technology companies.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Arkis BioSciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Arkis BioSciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Arkis Biosciences Comparisons
Competitors of Arkis BioSciences
Arkis BioSciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rapid Medical, CoAxia, Cerus Endovascular, Anaconda Biomed and Oxford Endovascular, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurovascular interventional devices including distal access catheters are developed.
|
|
| domain | founded_year | HQ Location |
Catheter-based treatment for cerebral ischemia
|
|
| domain | founded_year | HQ Location |
Interventional neuroradiology devices are developed for minimally invasive aneurysm treatment.
|
|
| domain | founded_year | HQ Location |
Medical devices for mechanical thromboectomy and clot removal are developed.
|
|
| domain | founded_year | HQ Location |
Metallic mesh devices for brain aneurysms are developed.
|
|
| domain | founded_year | HQ Location |
A hybrid polymer-metal stent for brain aneurysms is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Arkis Biosciences
Frequently Asked Questions about Arkis BioSciences
When was Arkis BioSciences founded?
Arkis BioSciences was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Where is Arkis BioSciences located?
Arkis BioSciences is headquartered in Knoxville, United States. It is registered at Knoxville, Tennessee, United States.
Is Arkis BioSciences a funded company?
Arkis BioSciences is a funded company, having raised a total of $9.38M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.5M, raised on Mar 01, 2013.
What does Arkis BioSciences do?
Arkis BioSciences develops technology for the neurosurgical treatments for intracranial hypertension arising from hydrocephalus, traumatic brain injury, hemorrhagic stroke and similar disorders. Their product offering includes Tunneling Guidewire Kit - shunt passer that combines a tunneling instrument with the precision of guidewire steering; Endexo molecule - a self-locating fluoro-oligomeric polymer that results in a passivated surface, thereby reducing protein adsorption, platelet adhesion and activation, and thrombus formation in catheter lumens.
Who are the top competitors of Arkis BioSciences?
Arkis BioSciences's top competitors include Rapid Medical, Fluid Biomed and Anaconda Biomed.
Who are Arkis BioSciences's investors?
Arkis BioSciences has 4 investors. Key investors include Integra LifeSciences, Innova Memphis, The Lighthouse Fund, and Angel Capital Group.